SCHEMBL31537993

SCHEMBL31537993

CNN1CCc2ccc([N+](=O)[O-])cc2C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 3/20 0.44
▸ DRD1 P21728 3/20 0.44
▸ CASP1 P29466 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ CASP4 P49662 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ CASP9 P55211 1/20 0.43
▸ CASP6 P55212 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ PTPRC P08575 1/20 0.41
▸ S100A4 P26447 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ TDP2 O95551 1/20 0.40
▸ DRD2 P14416 2/20 0.39
▸ HTR2A P28223 2/20 0.39
▸ ALOX5 P09917 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15727806 0.81 HTR1A (0.50) HTR1ADRD1CASP1CASP3CASP4
SCHEMBL16559365 0.72 MAPT (0.61) CASP1CASP3CASP4CASP7CASP9
SCHEMBL5298639 0.72 CASP1 (0.53) HTR1ADRD1CASP1CASP3CASP4
SCHEMBL6181379 0.71 PTPRC (0.50) HTR1ACASP1CASP3CASP4CASP7
SCHEMBL7423871 0.71 L3MBTL1 (0.41) HTR1ADRD1CASP1CASP3CASP4
SCHEMBL30954730 0.71 BAZ1A (0.58) CASP3ACHEPTPRCS100A4MAPT
SCHEMBL568785 0.71 BAZ1A (0.58) CASP3ACHEPTPRCS100A4MAPT
SCHEMBL798816 0.70 ROCK1 (0.44) HTR1ADRD1CASP1CASP3CASP4
SCHEMBL28549286 0.70 ALOX5 (0.55) CASP1CASP3CASP4CASP7CASP9
SCHEMBL7420931 0.70 ACHE (0.39) HTR1ADRD1CASP1CASP3CASP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119604287-A Heterocyclic PAD4 inhibitors 细胞基因公司 2025-03-11 — — CN disclosed
Send feedback